Signature scores were greater in tumors having non-silent TSC1 or TSC2 mutations versus other bladder tumors (Figure 4E) indicating that these cancers have an identifiable gene expression signature derived from inactivation of TSC1 or TSC2. This evidence concerns the gene TSC1 and cancer.